13F-HR filed by Vestal Point Capital, LP
Vestal Point Capital, LP filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 68 holding rows worth $4,279,457,817.
- Accession
- 0001974915-26-000005
- Filer
- CIK 1974915
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 68 entries on the cover page, a total value of $4,279,457,817 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,279,457,817 with VALUE read as dollars as filed, 13F file number 028-23784. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 6,025,000 | $344,750,500 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 1,880,000 | $316,845,800 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 2,349,443 | $313,086,774 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 435,000 | $235,696,050 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 4,000,000 | $203,000,000 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 8,050,000 | $195,293,000 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 5,250,000 | $155,872,500 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 19,415,000 | $132,216,150 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 1,575,000 | $128,378,250 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 1,400,000 | $127,036,000 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 1,400,000 | $120,526,000 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 1,550,000 | $113,367,000 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 4,600,000 | $111,320,000 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 670,000 | $102,007,500 | dollars as filed | |
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 375,000 | $100,020,000 | dollars as filed | |
| ASTRAZENECA PLC ORD | G0593M107 | ADR | 450,000 | $85,329,000 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 2,000,000 | $85,320,000 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 450,000 | $84,276,000 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 8,300,000 | $83,000,000 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 3,375,000 | $74,958,750 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 1,000,000 | $69,810,000 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 850,000 | $67,158,500 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 1,050,000 | $66,087,000 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 6,175,000 | $62,552,750 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 3,100,000 | $57,815,000 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 1,800,000 | $57,150,000 | dollars as filed | |
| REPLIGEN CORP COM | 759916109 | Stock | 400,000 | $54,576,000 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 800,000 | $46,096,000 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 935,000 | $43,066,100 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 700,000 | $42,252,000 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 545,000 | $38,259,000 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 65,000 | $34,901,750 | dollars as filed | |
| ALCON AG ORD SHS | H01301128 | Stock | 500,000 | $33,550,000 | dollars as filed | |
| MYRIAD GENETICS INC | 62855J104 | COM | 5,735,000 | $32,746,850 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 730,000 | $30,419,100 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 1,630,000 | $29,340,000 | dollars as filed | |
| GE HEALTHCARE TECHNOLOGIES INC COMMON STOCK | 36266G107 | Stock | 450,000 | $28,804,500 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 250,000 | $26,655,000 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 680,000 | $26,526,800 | dollars as filed | |
| BETA BIONICS INC | 08659B102 | COMMON STOCK | 1,600,000 | $25,072,000 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 40,000 | $24,941,600 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 2,160,000 | $21,578,400 | dollars as filed | |
| ALTO NEUROSCIENCE INC COM SHS | 02157Q109 | Stock | 785,000 | $20,716,150 | dollars as filed | |
| FIRST TRACKS BIOTHERAPEUTICS | 337185102 | ORD SHS *A* | 1,013,000 | $20,381,560 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 4,320,000 | $20,109,600 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 2,720,000 | $16,755,200 | dollars as filed | |
| DAMORA THERAPEUTICS INC | 36322Q206 | COMMON STOCK | 575,000 | $14,955,750 | dollars as filed | |
| SPYGLASS PHARMA INC | 85220G109 | COMMON STOCK | 670,000 | $14,914,200 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 425,000 | $14,609,375 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 775,000 | $14,322,000 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 1,000,000 | $13,290,000 | dollars as filed | |
| KAILERA THERAPEUTICS INC | 482931102 | COMMON STOCK | 575,000 | $12,667,250 | dollars as filed | |
| ANTERIS TECHNOLOGIES GLOBAL | 03675P102 | COMMON STOCK | 1,010,000 | $9,948,500 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 365,000 | $9,263,700 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 2,625,000 | $9,187,500 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 1,825,699 | $8,325,187 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 304,669 | $7,906,161 | dollars as filed | |
| MONOPAR THERAPEUTICS INC | 61023L207 | COMMON STOCK | 75,727 | $7,011,563 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 1,173,956 | $6,926,340 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 418,551 | $5,236,073 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 2,500,000 | $5,225,000 | dollars as filed | |
| IBIO INC | 451033708 | CMN | 2,600,000 | $4,550,000 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 535,452 | $4,139,044 | dollars as filed | |
| ENGENE THERAPEUTICS INC | 29286X101 | COM | 1,667,430 | $2,884,654 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 382,999 | $1,991,595 | dollars as filed | |
| NYXOAH S A | B6S7WD106 | SHS | 843,461 | $1,425,449 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 53,439 | $777,537 | dollars as filed | |
| APREA THERAPEUTICS INC | 03836J201 | COM NEW | 350,000 | $280,805 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001974915-26-000005 | this filing | 2026-08-14 | acceptance time not in the bulk data set |